David M. Berman - 16 Feb 2024 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
HEAD OF R&D
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Issuer symbol
IMCR
Transactions as of
16 Feb 2024
Net transactions value
$0
Form type
4
Filing time
21 Feb 2024, 16:15:38 UTC
Previous filing
02 Jan 2024
Next filing
28 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Employee Share Option (Right to Buy) Award $0 +111,244 $0.000000 111,244 16 Feb 2024 Ordinary Shares 111,244 $70.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.